Shanghai Medicilon Inc.’s Net Profit Rose 31.6% in First Quarter of 2023

Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) (688202.SH) reported a net profit of 101.6 million yuan in the first quarter of 2023, up 31.6% year-on-year.

Meanwhile, the company posted 451.4 million yuan in revenue, up 26.8% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 763.4 million yuan in total liabilities, with a liability-to-asset ratio of 30.9%.